Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
33 studies found for:    "prostate cancer" and "san diego" and "recruiting"
Show Display Options
Rank Status Study
1 Unknown  Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients
Condition: Prostate Cancer
Intervention: Biological: PSA/IL-2/GM-CSF
2 Recruiting Genomics in Michigan Impacting Observation or Radiation
Condition: Prostate Cancer
Intervention: Other: Decipher Prostate Cancer Classifier
3 Recruiting CyberKnife Radiosurgery for Localized Prostatic Carcinoma
Condition: Prostate Cancer
Intervention: Radiation: CyberKnife Radiosurgery
4 Recruiting Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer
Condition: Localized Prostate Cancer
Intervention: Drug: Ad5-SGE-REIC/Dkk3
5 Recruiting Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: Stereotactic Radiosurgery using the Novalis Tx
6 Recruiting Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
Conditions: Hepatocellular Carcinoma;   Renal Cell Carcinoma;   Melanoma;   Prostate Adenocarcinoma
Intervention: Biological: PEG-BCT-100
7 Recruiting Decipher Genomics Resource Information Database
Condition: Prostate Cancer
Interventions: Other: Decipher Prostate Cancer Classifier;   Other: Decipher Genomics Resource Information Database (GRID)
8 Recruiting Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Condition: Prostatic Neoplasm
Intervention: Radiation: radiation therapy
9 Recruiting A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Leuprolide
10 Recruiting IMbassador250: A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Drug: Atezolizumab;   Drug: Enzalutamide
11 Recruiting A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
Condition: Prostate Cancer Metastatic
Interventions: Drug: LY3023414;   Drug: Enzalutamide;   Drug: Placebo
12 Recruiting Prospective Prolaris Value and Efficacy
Condition: Prostate Cancer
Intervention: Behavioral: Prolaris
13 Recruiting Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
Condition: Metastatic Castrate Resistant Prostate Cancer
Interventions: Biological: Dendritic Cells DCVAC;   Biological: Placebo;   Drug: Docetaxel;   Drug: Taxotere
14 Recruiting PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Conditions: Stage I Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Biological: Rilimogene Galvacirepvec
15 Recruiting CyberKnife Radiosurgery for Locally Recurrent Prostate CA
Condition: Recurrent Prostate Cancer
Intervention: Radiation: CyberKnife Radiosurgery
16 Recruiting Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer (ARAMIS)
Conditions: Prostate Cancer Non-Metastatic;   Castration-Resistant
Interventions: Drug: BAY1841788 (ODM-201);   Drug: Placebo
17 Recruiting An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Condition: Prostatic Neoplasms
Interventions: Drug: Apalutamide;   Drug: Bicalutamide;   Drug: Bicalutamide Placebo;   Drug: Apalutamide Placebo;   Drug: GnRH (agonist);   Radiation: 74-80 Grays (units of radiation)
18 Recruiting A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Condition: Metastatic Castration Resistant Prostate Cancer
Interventions: Drug: Rucaparib;   Drug: Abiraterone acetate or Enzalutamide or Docetaxel
19 Recruiting A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
Condition: Castration-Resistant Prostate Cancer
20 Recruiting Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Castration Levels of Testosterone;   Castration-Resistant Prostate Carcinoma;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation;   Prostate Carcinoma Metastatic in the Bone;   Prostate Small Cell Carcinoma;   PSA Progression;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cediranib;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.